International audience
-
July 1, 2022 (v1)Book sectionUploaded on: December 4, 2022
-
June 2022 (v1)Journal article
International audience
Uploaded on: February 22, 2023 -
June 2022 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
February 1, 2021 (v1)Journal article
Human Hedgehog receptor Patched1 (PTCH1) is able to efflux chemotherapeutics of different chemical structure out of cancer cells thus contributing to multidrug resistance phenomena in tumor treatment. A screening of natural compounds purified from marine sponges led to the identification of the first PTCH1 efflux inhibitor, panicein A...
Uploaded on: December 4, 2022 -
2022 (v1)Journal article
The development of inhibitors of key biological mechanisms involved in multidrug resistance (MDR) burden meets an important medical need but still represents a challenging task. Major MDR targets in both bacterial and cancer cells are multidrug efflux systems. Several aspects should be considered in the attempt to design efficient inhibitors of...
Uploaded on: December 4, 2022